Are you a new member? Sign up now
Login area
| Sign up
close
NIFUNAL - -
| ATC | B/G | Ingredients | code | Registration Nb | brand_name | Dosage | Presentation | Form | Route | Agent | Laboratory | man_country | Price | Pharmacist Margin | Startum | Responsible Party Name | Responsible Party Country | Exch_date | %SUBSIDY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Nifuroxazide - 220mg/5ml | 12412 | 78122/1 | NIFUNAL | Pharmacy Ain Mreisseh | Amriya Pharmaceutical Industries | Egypt | 227,109 L.L | 23.08 | A1 | Amriya Pharmaceutical Industries | Egypt | 13/01/20 |
Drug Substitutes
| ATC | B/G | Ingredients | code | Registration Nb | brand_name | Dosage | Presentation | Form | Route | Agent | Laboratory | man_country | Price | Pharmacist Margin | Startum | Responsible Party Name | Responsible Party Country | Exch_date | %SUBSIDY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| U9493/388 | QARZIBA | 4.5 mg/ml | 1 | Injectable lyophilised powder for solution | IV | Mersaco | Millmount Healthcare Limited | Ireland | L.L | ||||||||||
| U9492/388 | PADCEV | 30mg | 1 | Injectable powder for concentrate for solution | IV | Mersaco | Astellas Ireland Co Ltd | Ireland | L.L |
Sitemap
© Copyrights reserved to Ministry of Public Health 2026